BeStock  
Markets › Compare › MDGL vs DVA

MDGL vs DVA

Side-by-side comparison of price performance, valuation, growth, profitability, analyst targets and technical trend.

vsvs
MDGL · Madrigal Pharmaceuticals$493.62 ▼ 1.16%
DVA · DaVita$178.72 ▲ 0.02%

One year, rebased to 100

Each line starts at 100 so growth is directly comparable

73102132161190Oct 7, '25Apr 7, '26Oct 5, '26
  • MDGL +13.0%
  • DVA +36.4%

Head to head

MetricMDGLDVA
Price$493.62$178.72
Change today▼ 1.16%▲ 0.02%
Market cap$11.40B$11.40B
Return, 3 months-9.5%-23.7%
Return, year to date-15.2%+57.3%
Return, 1 year+11.6%+39.5%
P/E (TTM)-35.314.7
P/B21.8-14.9
P/E percentile vs own 5y––
Dividend yield––
Revenue growth (YoY, latest qtr)––
Net profit growth (YoY)––
Gross margin––
Operating margin––
Net margin––
Return on equity––
Analyst target vs. price––
Analyst buy share––
RSI (14)3445
30-day volatility25.1%31.5%
Max drawdown, 1 year-29.4%-27.9%
Trend readStrong downtrendLeaning bearish
Analyst consensus––

Green cells mark the best value in each row where "better" is clear-cut (lower P/E, higher margin). That is a reading of the numbers, not a recommendation. Financials are in each company's reporting currency.

What the numbers say

  • MDGL is the largest of the group by market value.
  • DVA has returned the most over the past year.
  • MDGL carries the lowest trailing P/E.
  • MDGL has been the calmest stock over the last 30 days.

Go deeper

Scroll to Top